In Brief: Dr. Kremer's PMA
This article was originally published in The Gray Sheet
Executive Summary
Dr. Kremer's PMA: FDA Ophthalmic Devices Panel recommends against approval of a single-site premarket approval application sponsored by Frederic Kremer, MD, for a system to perform laser- assisted in situ keratomileusis. In a 4-2 vote, panel members cite poor patient accountability and inadequate standardization of post-operative patient evaluation. Kremer's PMA for the Laser-K laser-based system included data on 2,500 patients in two study cohorts. Uncorrected visual acuity at one-year follow-up was 92.2% for one group, 87.4% for the other cohort. The panel's rejection of the PMA likely will deal a blow to a licensing agreement between Kremer and Lasersight. Under the deal, Kremer must obtain a PMA approval allowing Lasersight to commercialize a LASIK system by July 28, or else the company can return the technology to Kremer...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.